MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 12 filers reported holding MOLECULIN BIOTECH INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $472,000 | -7.3% | 591,954 | -5.4% | 0.00% | – |
| Q3 2020 | $509,000 | -66.0% | 625,976 | -59.5% | 0.00% | – |
| Q2 2020 | $1,497,000 | -7.4% | 1,546,163 | -41.7% | 0.00% | – |
| Q1 2020 | $1,617,000 | -32.1% | 2,651,004 | +1.9% | 0.00% | – |
| Q4 2019 | $2,381,000 | -17.6% | 2,602,114 | -0.0% | 0.00% | – |
| Q3 2019 | $2,889,000 | -13.8% | 2,602,360 | -2.9% | 0.00% | – |
| Q2 2019 | $3,350,000 | +417.8% | 2,680,010 | +235.4% | 0.00% | – |
| Q1 2019 | $647,000 | -9.6% | 799,049 | +16.1% | 0.00% | – |
| Q4 2018 | $716,000 | -32.8% | 688,321 | +3.4% | 0.00% | – |
| Q3 2018 | $1,066,000 | -9.8% | 665,941 | +0.8% | 0.00% | – |
| Q2 2018 | $1,182,000 | +20.1% | 660,458 | +20.9% | 0.00% | – |
| Q1 2018 | $984,000 | +15.1% | 546,422 | +18.9% | 0.00% | – |
| Q4 2017 | $855,000 | -16.0% | 459,642 | +7.9% | 0.00% | – |
| Q3 2017 | $1,018,000 | +61.3% | 426,087 | +26.3% | 0.00% | – |
| Q2 2017 | $631,000 | +104.2% | 337,321 | +27.7% | 0.00% | – |
| Q1 2017 | $309,000 | +653.7% | 264,160 | +1371.0% | 0.00% | – |
| Q4 2016 | $41,000 | – | 17,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|